The FX PostThe FX Post
    What's Hot

    Risk mitigation

    July 18, 2025

    Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn

    July 17, 2025

    Republicans declared it ‘crypto’ week in the House. It’s not going as planned

    July 16, 2025
    The FX Post The FX Post
    • Best Fx Robots
    • Forex
      • News
      • Forex 101
      • Forex Forecasts
      • Broker Reviews
    • Crypto
      • News
      • Crypto 101
      • Crypto Forecasts
      • Crypto Reviews
    • Indices
      • News
      • Analysis
      • Commodities
      • Reviews
    • Automated Trading
      • Forex Signals
      • Forex Robots
      • Copy Trading
    • Top
      • Best Forex Robots
    The FX PostThe FX Post
    Home ยป New Data on Experimental Treatment for Prostate Cancer
    News

    New Data on Experimental Treatment for Prostate Cancer

    December 18, 20232 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Reddit

    Shares of Lantheus Holdings Inc. (LNTH) and Point Biopharma Global Inc. (PNT) experienced a sharp decline in premarket trading on Monday following the release of new data from a trial involving their experimental treatment for prostate cancer. This latest therapy, known as Lu-PNT2002, successfully achieved the primary objective of the trial, exhibiting a median progression-free survival rate of 9.5 months. This result far surpassed the six-month progression-free survival rate observed in patients receiving an alternative treatment known as an androgen receptor pathway inhibitor.

    Comparing Lu-PNT2002 to Novartis AG’s Pluvicto

    Investors were particularly interested in how Lu-PNT2002 would measure up against Novartis AG’s Pluvicto, another radioligand therapy that administers targeted radiation to cancer cells while minimizing damage to healthy cells. In October, Novartis released data that demonstrated Pluvicto’s median progression-free survival rate of 12 months, compared to only 5.6 months for patients receiving androgen receptor pathway inhibitors.

    Market Reaction to the Trial Data

    In response to the new trial data, Lantheus stock experienced a 20% decline in premarket trading on Monday. However, it is still showing a promising overall performance, with shares up by 49% since the beginning of the year. Similarly, shares of Point Biopharma fell by 10.9% in premarket trading but have achieved a significant gain of 92% this year. On the other hand, Novartis American depositary receipts increased by 1.2% in premarket trading on Monday.

    The release of this trial data marks an important milestone in the development of new treatments for prostate cancer. As these companies continue to explore innovative therapies, close attention must be paid to further advancements in the field.

    Markets are invaded by algorithms
    Secure your passive income with algo-based trading systems
    Learn more
    Experimental Treatment Lu-PNT2002 Progression-Free Survival Prostate Cancer Radioligand Therapy
    Share. Facebook Twitter Pinterest LinkedIn Reddit

    Related Posts

    Risk mitigation

    July 18, 2025

    Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn

    July 17, 2025

    Republicans declared it ‘crypto’ week in the House. It’s not going as planned

    July 16, 2025

    SIM Mining Announces Global Launch of Next-Gen Cloud Mining Platform!

    July 15, 2025
    Add A Comment

    Leave A Reply Cancel Reply

      +  18  =  19

    Best FX Post
    Best Forex Robots (Expert Advisors) 2021

    Best Forex Robots (Expert Advisors) 2022: Passive Income From Algo Trading Systems

    July 7, 2021

    Top 10 Lending Platforms for Crypto Loans

    June 1, 2022
    forex eurusd trading charts

    Top 10 Best Forex Brokers In All Times

    June 1, 2022
    Recent Posts
    • Risk mitigation
    • Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn
    • Republicans declared it ‘crypto’ week in the House. It’s not going as planned
    • SIM Mining Announces Global Launch of Next-Gen Cloud Mining Platform!
    • RICH Miner leads the Ripple cloud mining revolution – converting XRP into daily stable income
    Featured Reviews

    Traders Connect Review

    May 18, 2023

    System Levels Review

    May 26, 2023
    TechBerry

    TechBerry Review: Pros, Cons, Recommendations

    September 18, 2021
    Categories
    • Analysis
    • Automated Trading
    • Best FX Post
    • Broker Reviews
    • Commodities
    • Copy Trading
    • Crypto
    • Crypto 101
    • Crypto Bots
    • Crypto Forecasts
    • Crypto Reviews
    • Crypto Robot
    • Forex
    • Forex 101
    • Forex Forecasts
    • Forex Robots
    • Forex Signals
    • Forex Signals
    • Guides
    • Indices
    • News
    • News
    • News
    • News
    • Reviews
    • Reviews
    • Uncategorized
    Twitter BlogLovin
    © 2025, Thefxpost.com.
    • Contact

    Type above and press Enter to search. Press Esc to cancel.